Organization: Health Canada
Year: 2023
Month: October
Request Number: A-2023-000821
Request Summary: Information as to whether or not the Abbreviated New Drug Submission (ANDS) for liraglutide accepted into review in August 2017 is on “intellectual property hold” as described in section 6.2 of Health Canada’s Guidance Document on Patented Medicines (Notice of Compliance) Regulations.
Disposition: No records exist
Number of pages: 0